(Canada, Ontario, Quebec, Ottawa)
|
COVID-19 - Vaccine
Stats (Canada, Ontario, Quebec, Ottawa) |
This page contains data about COVID-19 vaccine safety and the roll out in Canada, Ontario, and Quebec. The graphs are updated on a daily basis early morning each day.
You can also find COVID-19 stats for Global, Canada, Ontario, and Quebec and City of Ottawa, ON, Canada.
Table of Contents
1. Vaccine Safety (Canada)
2. Vaccine Dashboard (Canada, Ontario, Quebec)
3. Vaccine Daily # Administered (Canada, Ontario,
Quebec)
4. Vaccine Cumulative # Administered (Canada,
Ontario, Quebec)
5. Vaccine Coverage (Ontario, Quebec)
6. Vaccine Stats & Coverage (Ottawa)
7. Vaccine Effectiveness in Ontario
Vaccines in Canada are closely monitored with a surveillance network and safety information is published on a regular basis. The charts below show the latest safety data for the COVID-19 vaccines in Canada. So far there have been no safety issues identified with approved COVID-19 vaccines and no deaths reported from the vaccine in Canada with over 1 million doses given. More than 160 million doses have been given globally. This data is updated on a weekly basis. An adverse event is defined as any untoward medical occurrence which follows immunization and may not be causally related to usage of the vaccine. An adverse event is considered serious if it results in death, is life-threatening, requires in-patient hospitalization, results in persistent or significant disability, or results in a congenital anomaly/birth defect. The most frequently reported serious adverse event was anaphylaxis. The most frequently reported non-serious adverse events were pain at vaccination site, redness at site, swelling at site, warmth at site, and itching at site.
The following graph shows a comparison between the serious disease outcomes of people who get infected with COVID-19 (prolonged illness, hospitalization, ICU admission, ventilation, death) and the adverse event outcomes of people who get vaccinated (non-serious, serious, death). If you are trying to decide whether taking the COVID-19 is worth the risk vs getting infected naturally, the math is extremely clear. As you can see, the probability of having a serious disease outcome if you get infected with COVID-19 is hundreds or thousands of times higher than having a serious adverse event by taking the vaccine. Data sources: COVID-19 disease outcome stats and prolonged illness stats.
| |
|
|
Vaccine Daily # Administered
(Canada, Ontario, Quebec)
The graphs below show the 7-day rolling average of the daily # vaccines administered to people in Canada, Ontario, and Quebec. Data source for Canada and Provinces.
Vaccine Cumulative #
Administered (Canada, Ontario, Quebec)
The graphs below show the cumulative # vaccines administered to people in Canada, Ontario, and Quebec. Data source for Canada and Provinces.
Vaccine Coverage (Ontario,
Quebec)
The graph below shows vaccine coverage by age for Ontario. Source of data comes from Public Health Ontario. This will be updated weekly.
The graph below shows vaccine coverage by age for Quebec. Source of data comes from Province of Quebec. This will be updated weekly.
Vaccine Stats & Coverage
(Ottawa)
The information below shows the vaccine stats for the city of Ottawa, ON, Canada. Source of data comes from the Ottawa Vaccination Dashboard.
Vaccine Effectiveness in
Ontario
The graphs below show the effectiveness of the COVID-19 vaccines used in Ontario (see above for brands and usage) by displaying the distribution of symptomatic and asymptomatic cases, hospitalizations, and deaths for people who were partially vaccinated, fully vaccinated, and unvaccinated since December 14, 2020 when vaccination started. Source of data comes from the Public Health Ontario.
Partially vaccinated is defined as someone who is 14 or more days following the first dose of a 2-dose COVID-19 vaccine or 0 to less than 7 days after receiving the second dose.
Fully vaccinated is defined as someone who is 7 or more days following the second dose of a 2-dose COVID-19 vaccine.
Unvaccinated is defined as someone who has received 0 doses of a COVID-19 vaccine or 0 to less than 14 days after receiving the first dose of a 2-dose COVID-19 vaccine, before protection starts.
|
 |